{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006955",
      "entity_text" : "immunity",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P47741",
      "entity_text" : "OX40",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "For example, OX40 is a co-stimulatory receptor that is primarily expressed on activated T cells, and OX40 agonists have been shown to enhance antitumour immunity through the promotion of T cell proliferation and survival XREF_BIBR.",
  "reading_complete" : "2020-08-02T14:00:07Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:58:46Z",
  "trigger" : "enhance",
  "evidence" : [ "OX40 agonists have been shown to enhance antitumour immunity" ],
  "pmc_id" : "6096398",
  "score" : 0
}